IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Mr. Ari Bousbib is the Chairman of the Board of IQVIA Holdings Inc, joining the firm since 2016.
What is the price performance of IQV stock?
The current price of IQV is $177, it has increased 0.32% in the last trading day.
What are the primary business themes or industries for IQVIA Holdings Inc?
IQVIA Holdings Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is IQVIA Holdings Inc market cap?
IQVIA Holdings Inc's current market cap is $29.7B
Is IQVIA Holdings Inc a buy, sell, or hold?
According to wall street analysts, 25 analysts have made analyst ratings for IQVIA Holdings Inc, including 10 strong buy, 14 buy, 5 hold, 0 sell, and 10 strong sell